Registration Strip Icon for default Register for Free to get streaming real-time quotes, interactive charts, live options flow, and more.

CLVS

Clovis Oncology (CLVS)

Clovis Oncology Inc
Date:
Sort by:
 Showing the most relevant articles for your search:NASDAQ:CLVS
DateTimeSourceHeadlineSymbolCompany
05/01/20234:17PMEdgar (US Regulatory)Current Report Filing (8-k)NASDAQ:CLVSClovis Oncology Inc
04/14/20238:01AMEdgar (US Regulatory)Current Report Filing (8-k)NASDAQ:CLVSClovis Oncology Inc
04/06/20234:17PMEdgar (US Regulatory)Current Report Filing (8-k)NASDAQ:CLVSClovis Oncology Inc
03/02/20238:02AMEdgar (US Regulatory)Current Report Filing (8-k)NASDAQ:CLVSClovis Oncology Inc
02/16/20234:32PMEdgar (US Regulatory)Current Report Filing (8-k)NASDAQ:CLVSClovis Oncology Inc
02/13/20236:04AMEdgar (US Regulatory)Current Report Filing (8-k)NASDAQ:CLVSClovis Oncology Inc
02/10/20239:49AMEdgar (US Regulatory)Amended Statement of Ownership (sc 13g/a)NASDAQ:CLVSClovis Oncology Inc
01/12/20236:16AMEdgar (US Regulatory)Current Report Filing (8-k)NASDAQ:CLVSClovis Oncology Inc
12/29/20229:36AMEdgar (US Regulatory)Notification Filed by National Security Exchange to Report the Removal From Listing and Registration of Matured, Redeemed or Retired Securities Initial Filing Amendments (25-nse)NASDAQ:CLVSClovis Oncology Inc
12/13/20226:10AMEdgar (US Regulatory)Current Report Filing (8-k)NASDAQ:CLVSClovis Oncology Inc
12/13/20226:07AMEdgar (US Regulatory)Current Report Filing (8-k)NASDAQ:CLVSClovis Oncology Inc
12/12/20226:54AMDow Jones NewsClovis Oncology Shares Fall Premarket After Bankruptcy FilingNASDAQ:CLVSClovis Oncology Inc
12/12/202212:18AMBusiness WireClovis Oncology Files for Chapter 11 Protection and Enters into Agreement to Sell FAP-2286NASDAQ:CLVSClovis Oncology Inc
11/16/20224:16PMEdgar (US Regulatory)Current Report Filing (8-k)NASDAQ:CLVSClovis Oncology Inc
11/09/20228:12AMEdgar (US Regulatory)Quarterly Report (10-q)NASDAQ:CLVSClovis Oncology Inc
11/03/20224:18PMEdgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:CLVSClovis Oncology Inc
11/03/20224:17PMEdgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:CLVSClovis Oncology Inc
11/03/20224:17PMEdgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:CLVSClovis Oncology Inc
11/03/20224:17PMEdgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:CLVSClovis Oncology Inc
11/03/20224:17PMEdgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:CLVSClovis Oncology Inc
10/27/20225:05PMBusiness WireClovis Oncology Presents Data from TRITON3 Phase 3 Trial of Rubraca® (rucaparib) at the 29th Annual Prostate Cancer Foundation Scientific RetreatNASDAQ:CLVSClovis Oncology Inc
10/17/20223:45AMBusiness WireClovis Oncology Highlights Updated LuMIERE Phase 1 Data of Targeted Radiotherapy Candidate FAP-2286 at the 35th Annual EANM CongressNASDAQ:CLVSClovis Oncology Inc
10/04/20224:17PMEdgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:CLVSClovis Oncology Inc
10/03/20227:00AMBusiness WireTRITON3 Phase 3 Trial of Rubraca® (rucaparib) Achieves Primary Endpoint in Men with Metastatic Castration-Resistant Prostate Cancer with BRCA or ATM MutationsNASDAQ:CLVSClovis Oncology Inc
09/21/20228:00AMBusiness WireClovis Oncology and Isotopia Announce Lutetium-177 Clinical Supply AgreementNASDAQ:CLVSClovis Oncology Inc
09/13/20228:00AMBusiness WireClovis Oncology Submits Applications for Rubraca® Label Expansion in the US and European Union as First-line Maintenance Treatment in Women with Advanced Ovarian CancerNASDAQ:CLVSClovis Oncology Inc
09/12/20227:55AMTipRanksClovis (NASDAQ:CLVS) Jumps After Rubraca Shows Progression-Free Survival in Ovarian CancerNASDAQ:CLVSClovis Oncology Inc
09/11/202210:30AMBusiness WireClovis Oncology’s Rubraca® (Rucaparib) as First-Line Maintenance Treatment Improves Progression-Free Survival in Women with Advanced Ovarian Cancer Across Disease Risk SubgroupsNASDAQ:CLVSClovis Oncology Inc
09/06/20224:16PMEdgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:CLVSClovis Oncology Inc
09/06/20224:16PMEdgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:CLVSClovis Oncology Inc
 Showing the most relevant articles for your search:NASDAQ:CLVS

Your Recent History

Delayed Upgrade Clock